Nasus Pharma NSRX
NYSE NSRX
$2.91 -0.02 (-0.87%)
As of: Nov 10, 2026 · 1:28 PM EST

Nasus Pharma (NSRX) Common Equity (2024 - 2026)

Updated

Nasus Pharma (NSRX) posted Common Equity of $11 million for Q2 2026, compared with -$4.31 million a year earlier.

Analysis

Nasus Pharma (NSRX) Common Equity (2024 - 2026) Analysis & Trends

At the end of FY2025, Nasus Pharma's Common Equity came in at $2.77 million.

  • In prior years, Nasus Pharma's Common Equity was -$3.21 million in FY2024 and -$3.8 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 40.27 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 81.53 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -4.58 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 44.95 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 41.95 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 50.37 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 14.35 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 13.04 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 89.30 Bn
10 Nasus Pharma 23.71 Mn 23.71 Mn - 2.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.00 Mn
Dec 31, 2025 2.77 Mn
Jun 30, 2025 -4.31 Mn
Dec 31, 2024 -3.21 Mn
API Access

Nasus Pharma Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=NSRX&period=max&api_key=YOUR_API_KEY